换一批Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes.
第一作者：
Stepan M,Esagian
第一单位：
Faculty of Medicine, School of Health Sciences, Democritus University of Thrace, Alexandroupolis, Greece.
作者：
Stepan M,Esagian [1]
;
Ali Raza,Khaki [2]
;
Leonidas N,Diamantopoulos [3]
;
Lucia,Carril-Ajuria [4]
;
Daniel,Castellano [4]
;
Ivan,De Kouchkovsky [5]
;
Joseph J,Park [6]
;
Ajjai,Alva [6]
;
Mehmet A,Bilen [7]
;
Tyler F,Stewart [8]
;
Rana R,McKay [8]
;
Victor S,Santos [9]
;
Neeraj,Agarwal [9]
;
Jayanshu,Jain [10]
;
Yousef,Zakharia [11]
;
Rafael,Morales-Barrera [12]
;
Michael E,Devitt [13]
;
Ariel,Nelson [14]
;
Christopher J,Hoimes [15]
;
Evan,Shreck [16]
;
Benjamin A,Gartrell [16]
;
Alex,Sankin [16]
;
Abhishek,Tripathi [17]
;
Roubini,Zakopoulou [18]
;
Aristotelis,Bamias [19]
;
Alejo,Rodriguez-Vida [20]
;
Alexandra,Drakaki [21]
;
Sandy,Liu [21]
;
Vivek,Kumar [22]
;
Mark P,Lythgoe [23]
;
David J,Pinato [23]
;
Jure,Murgic [24]
;
Ana,Fröbe [25]
;
Monika,Joshi [26]
;
Pedro,Isaacsson Velho [27]
;
Noah,Hahn [27]
;
Lucia,Alonso Buznego [28]
;
Ignacio,Duran [28]
;
Marcus,Moses [29]
;
Pedro,Barata [29]
;
Matthew D,Galsky [30]
;
Guru,Sonpavde [31]
;
Evan Y,Yu [2]
;
Pavlos,Msaouel [32]
;
Vadim S,Koshkin [5]
;
Petros,Grivas [2]
作者单位：
Faculty of Medicine, School of Health Sciences, Democritus University of Thrace, Alexandroupolis, Greece.
[1]
Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.;Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
[2]
Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
[3]
Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
[4]
Division of Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
[5]
Division of Oncology, Department of Medicine, University of Michigan, Ann Arbor, MI, USA.
[6]
Winship Cancer Institute of Emory University, Atlanta, GA, USA.
[7]
Division of Hematology/Oncology, Department of Medicine, University of California, San Diego, La Jolla, CA, USA.
[8]
Division of Oncology, Department of Medicine, University of Utah, Salt Lake City, UT, USA.
[9]
Department of Medicine, University of Iowa, Iowa City, IA, USA.
[10]
Division of Oncology, Department of Medicine, University of Iowa, Iowa City, IA, USA.
[11]
Vall d'Hebron Institute of Oncology, Vall d' Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.
[12]
Division of Hematology/Oncology, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA, USA.
[13]
Division of Medical Oncology, Seidman Cancer Center at Case Comprehensive Cancer Center, Cleveland, OH, USA.;Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
[14]
Division of Medical Oncology, Seidman Cancer Center at Case Comprehensive Cancer Center, Cleveland, OH, USA.;Division of Medical Oncology, Duke University, Durham, NC, USA.
[15]
Department of Medical Oncology and Urology, Montefiore Medical Center, Bronx, NY, USA.
[16]
Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
[17]
Department of Clinical Therapeutics, School of Medicine, Alexandra General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
[18]
2nd Propaedeutic Dept of Internal Medicine, School of Medicine, ATTIKON University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
[19]
Medical Oncology Department, Hospital del Mar Research Institute, Barcelona, Spain.
[20]
Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
[21]
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
[22]
Department of Surgery and Cancer, Imperial College London, London, UK.
[23]
Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia.
[24]
Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia.;School of Dental Medicine, Zagreb, Croatia.
[25]
Division of Hematology/Oncology, Department of Medicine, Penn State Cancer Institute, Hershey, PA, USA.
[26]
Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
[27]
Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain.
[28]
Deming Department of Medicine, Section of Hematology/Oncology, Tulane University, New Orleans, LA, USA.
[29]
Division of Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
[30]
Genitourinary Oncology Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
[31]
Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.;Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
[32]
主题词
老年人(Aged);老年人, 80以上(Aged, 80 and over);癌, 移行细胞(Carcinoma, Transitional Cell);队列研究(Cohort Studies);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);肿瘤分期(Neoplasm Staging);回顾性研究(Retrospective Studies);治疗结果(Treatment Outcome);泌尿系肿瘤(Urologic Neoplasms)
DOI
10.1111/bju.15324
PMID
33556233
发布时间
2024-03-15
- 浏览0
BJU international
BJU international
196-205页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
